Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05218863
Other study ID # AMESI Study
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 6, 2022
Est. completion date April 5, 2023

Study information

Verified date May 2023
Source University of Tartu
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective, multicentre observational study screening all adult patients admitted to a participating hospital over a 6-month study period (may be adjusted to 4-8 months according to recruitment) and including all patients with suspicion of or confirmed acute mesenteric ischaemia (AMI). Only admission data and hospital mortality outcome will be collected for patients in whom suspicion of AMI is not confirmed. For patients with confirmed AMI full data collection regarding diagnostics, management and long-term outcome is required. Investigators aim to recruit 40-50 sites with expected median of 10-20 patients with confirmed AMI per site during the study period (naturally depending on the size of the hospital). The start of the study is planned for Spring 2022. The aim of the study is to identify the incidence of AMI and its different forms in adult hospitalized patients, and to describe patient characteristics (demographic, clinical and laboratory) at baseline, applied diagnostics and management, as well as outcomes in patients with AMI. An additional aim is to compare the baseline characteristics and outcomes of patients with confirmed AMI to those of patients with suspected AMI in whom the diagnosis was not confirmed.


Recruitment information / eligibility

Status Completed
Enrollment 709
Est. completion date April 5, 2023
Est. primary completion date April 5, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: All patients with suspected AMI Exclusion Criteria: Age <18 years Consent declined by patient or next of kin Chronic mesenteric ischaemia without an acute event

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
Estonia North Estonian Regional Hospital Tallinn
Estonia Tartu University Hospital Tartu
Switzerland Kantonsspital Luzern Luzern

Sponsors (1)

Lead Sponsor Collaborator
University of Tartu

Countries where clinical trial is conducted

Estonia,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of AMI Incidence of AMI in hospitalized adult patients in acute care hospitals 6 months
Secondary 30 days survival of AMI survival of patients with confirmed AMI 30 days after admission/suspicion of AMI/study inclusion
Secondary Proportion of different forms of AMI Proportion of each form of AMI from all AMI cases 6 months
Secondary Time to diagnosis Time from symptoms to diagnosis through study completion, study duration 6 months
Secondary Time to treatment Time from diagnosis to treatment through study completion, study duration 6 months
Secondary Treatment Surgery, endovascular intervention or palliation through study completion, study duration 6 months
Secondary 1 year survival Survival of patients with AMI 1 year after diagnosis 1 year
Secondary Quality of life score EQ-5D-5L (EuroQoL - European Quality of Life ), 5-25 points, the lower score means better outcome 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05194527 - The Detrimental Course of Acute Intestinal Ischemia
Not yet recruiting NCT06387147 - ORal Antibiotics In Acute Mesenteric Ischemia Phase 3
Completed NCT04867499 - Epidemiology of Acute Mesenteric Ischemia
Not yet recruiting NCT06212921 - Biomarkers in Prediction of AMI N/A
Recruiting NCT03518099 - Searching Biomarkers of Acute Intestinal Ischemic Injuries N/A
Not yet recruiting NCT06428240 - Acute Mesenteric Ischemia, Reality in Catalonia
Active, not recruiting NCT06365827 - Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)
Recruiting NCT06445660 - The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
Completed NCT05706012 - Antithrombotic Management of Acute Mesenteric Ischaemia
Not yet recruiting NCT06310395 - Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years
Completed NCT05665946 - Acute Intestinal Necrosis- the Preoperative Diagnostic Approach
Recruiting NCT01788904 - Plasma i-FABP as Predictor for Irreversible Bowel Ischemia N/A
Recruiting NCT02772913 - Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study N/A